The incidence of gestational diabetes mellitus (GDM) in pregnancy is increasing worldwide. In addition to the perinatal complications of GDM, there are also long-term health risks, as shown by the increased incidence of type 2 diabetes and cardiovascular disease. However, knowledge about the predictive factors for long-term metabolic health outcomes in women after GDM is still limited.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Psychooncology
Communication as the key to therapy adherence
- How do weight loss interventions affect the muscles?
Reflective evaluation: do not neglect qualitative aspects
- From biomarkers to gene therapies
Getting to know ataxias
- Evidence-based therapy for psoriasis in difficult locations
IL-23 inhibition in scalp psoriasis: what’s new?
- Obesity in the family practice
Aim for realistic goals and avoid apportioning blame
- Evidence, pathophysiology and management in the light of current data
Heart failure with improved ejection fraction (HFimpEF)
- Early rheumatoid arthritis
C1M has potential as a biomarker
- Osteoporosis